UNSPSC 51343811: Abacavir/dolutegravir/lamivudine

This classification denotes a combination drug for treatment of HIV. The first component, ABACAVIR, has US FDA Unique Ingredient Identifier of WR2TIP26VS. The second component, DOLUTEGRAVIR, has US FDA Unique Ingredient Identifier of DKO1W9H7M1. The third component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95.

UNSPSC 51343811 Abacavir/dolutegravir/lamivudine is a Commodity code that does not reflect the scope of work actually being solicited under it by state and local governments. Recent state and local contract opportunities tagged with this code span pharmaceutical distribution, emergency medical services supplies, pharmacy benefits program networks, and forensic drug reference materials—none of which align with the procurement of a specific antiretroviral medication combination. The code appears to be applied inconsistently or incorrectly across diverse healthcare and public safety procurement activities that fall outside its nominal scope. The issuing bodies include county health departments, county fire departments, healthcare centers, forensic laboratories, and county public health authorities across multiple states.

The recent opportunities reveal a fragmented landscape with no meaningful concentration in any single jurisdiction or service area. The City of Tucson Fire Department solicited basic and advanced life support pharmaceuticals and supplies through an RFP due June 24, 2026, federally funded through ARPA, HUD, and FTA grants with prevailing wage and Section 3 labor requirements. West Texas Centers for Mental Health and Mental Retardation requested proposals for prescription and pharmacy services for over 7,000 individuals across 35 service sites due August 21, 2026, with compensation structured as tiered markups plus per-prescription dispensing fees. Dane County issued an RFP for pharmaceutical services to Badger Prairie Health Care Center due October 22, 2026, with a local-vendor preference and annual funding at $125,000. Pinellas County, Florida procured certified reference materials and drug standards for forensic laboratory analysis due April 23, 2026, with federal funding through the Paul Coverdell Forensic Sciences Improvement Act Program. No recent activity under this code supports pursuit of antiretroviral medication supply contracts.